Unlearn

Unlearn is an AI-powered platform for clinical development that provides a unified workspace for trial design, planning, and analysis. It replaces siloed workflows with integrated tools: TrialPioneer for upstream trial design, Scout for literature and regulatory search, Hindsight for historical data exploration, and SimLab for scenario comparison. Unlearn also offers AI-generated digital twins that forecast expected control outcomes in clinical trials, reducing variability and enabling smaller sample sizes. The digital twin methodology is qualified by the EMA and aligned with FDA guidance. Unlearn works across neuroscience, immunology, and metabolic disease, helping sponsors reach design decisions faster, reduce trial size and cost, and accelerate time to readout. Real-world results include a 33% reduction in control arm size and over 4 months of enrollment time saved.

Key Benefits

• Unified workspace for trial design, planning, and analysis
• AI-generated digital twins reduce trial size and cost
• EMA qualified and aligned with FDA guidance
• Trusted by leading biopharma sponsors